Melvin Rothberg serves as Executive at Lotus Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Melvin Rothberg has executed 2 insider transactions totaling $30.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 2, 2008 involved selling 30,000 shares valued at $30.3K.
Melvin Rothberg currently holds 30,000 shares of Lotus Pharmaceuticals, Inc. (LTUS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Melvin Rothberg has been a net seller of LTUS stock. They have purchased $0 and sold $30.3K worth of shares.
Melvin Rothberg's most recent insider trade was on Jan 2, 2008, when they sold 30,000 shares at $1.01 per share.
Get notified when new Form 4 filings are submitted
| $1.00 |
| Discretionary |